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for relapse. Our aim was to compare the incidence of 
resistance to 2nd generation FQ, such as ofloxacin, 
pefloxacin and ciprofloxacin, in bacteria isolated from 
blood cultures of patients who received (group 1) and in 
those who not received PQF (group 2) during the period 
1996-2000. 
Results: Group 1 consisted of 102 febrile episodes in 76 
pts. with a median age of 7.9 years. 72.5% of episodes 
were in HSCT pts. and 23.5 % in relapsed pts. They were 
classified as MID in 24%, as CID in 13 % and as FUO in 
63% of cases. Septic shock was present in 5/102 episodes 
(5%). Early mortality (within 30 days) was observed in 
3/76 pts (4%). The strains isolated from blood were 19 
(13 G+, 5 G-, 1 fungus) and 13 were tested for FQ 
susceptibility: resistance to FQ was observed in 3/S 
G+(37%) and 3/5 G- (60%) , respectively. 
Group 2 consisted of 916 febrile episodes in 341 pts 
with a median age of 5.2 years. Only a minority of 
episodes were in HSCT pts (5%) or in relapsed pts 
(18%). They were classified as MID in 25%, as CID in 
11% and as FUO in 64% of cases. Septic shock was 
present in 23/916 episodes (2.5%). Early mortality was 
observed in 51/341 (15%) pts. The strains isolated from 
blood were 186 (105 G+, 63 G- and 18 fungi) and 156 
were tested for FQ susceptibility: resistance to FQ 
was found in 22/95 G+ (23%) and 4/61 G- (6.5%), 
respectively. 
Conclusions: this data show a major incidence of 
sistemic infections by G- FQ resistent strain in patients 
who were on PFQ although that has not been translated 
in a major incidence of clinically or microbiologically 
demonstrated infections or in a major mortality rate. G+ 
strains appeared intrinsically more resistent to FQ 
because a high rate of resistence was found also in pts 
who were not receiving PFQ. Prospective randomized 
studies are needed to define the role of PFQ prophylaxis 
in reducing severe infections and early mortality in high- 
risk patients. 
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Introduction: The differences in antifungal susceptibility 
of C. glabrata associated with bloodstream invasion, 
infection, and colonization are uncertain. Most systemic 
candidiasis arises from host’s endogenous flora so it is 
important to evaluate the prevalence of drug resistance 
among organisms comprising yeast reservoir to deter- 
mine appropriate prophylactic, preemptive, and empiric 
therapy, especially in high-risk settings. 
Methods: Evaluation of all clinical yeast isolates during 
1998 to 1999 from three large teaching hospitals in New 
York City was performed prospectively. Candida spp. re- 
identification (under code) and susceptibility according 
to NCCLS guidelines was performed at The State 
Department of Health, Albany, New York. 
Results: The level of resistance for fluconazole (FLU) 
and itraconazole (ITRA) among 347 C. glabrata isolates 
was 10.7% and 18.2% respectively. In 33 bloodstream, 
and 314 isolates from other body sites, MICKI for FLU 
was 32.0 Kg/ml and ITRA 1.0 kg/ml. A significant 
difference was observed between isolates from medical 
centers caring for substantial population of patients with 
cancer (Center-I), and AIDS (Center-III) (MI&I for 
FLU 32.0 and >64.0 pg/ml, respectively) and C. glabrata 
isolated from patients at a community-based university 
hospital (Center-II) (MI& for FLU 16.0 kg/ml; 
P=O.OOl). A similar difference for ITRA was not 
significant (P= >0.5). A higher frequency of resistance 
was also noticed among respiratory and urinary tract 
isolates (FLU MI& 264.0 pg/ml). In contract, 46 
isolates obtained from gastrointestinal tract MI&o for 
FLU was ~8.0 kg/ml (P= 0.01). 
Conclusions: The results of present study indicate that 
triazole-derived antifungal susceptibility may not 
significantly differ among C. glabrata associated with 
hematogenous invasion, systemic infection, and colon- 
ization. 
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Introduction: Systemic scedosporiasis due to the 
anamorph/ asexual state of Pseudallescheria boydii has 
emerged as an important cause of opportunistic invasive 
mycosis in the severely immunosuppressed individuals. 
Case report: A 34-year-old man presented with fever 
and hemoptysis, while on oral itraconazole prophylaxis 
8 months after second allogeneic marrow transplant- 
ation for relapsed Philadelphia chromosome positive 
chronic myelogenous leukemia. His WBC was 1400 
